A pre-treatment with EGCG consistently reduced the level of IL-1β-induced secretion of IL-8 by 68.0–93.0% in orbital fibroblasts from patietns with TAO and non-TAO (Fig 2). This evidence concerns the gene IL1B and thromboangiitis obliterans.